6-Hydroxy-6-phenylhexan-2-one | 41368-19-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 6-Hydroxy-6-phenylhexan-2-one
• CAS: 41368-19-8
• 化学式: C₁₂H₁₆O₂
• 分子量: 192.258
• InChiKey: NNSZYAGZFQVCKZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  6-Hydroxy-6-phenylhexan-2-one 、 对甲基苯甲酰氯 在 四甲基乙二胺 作用下， 以 二氯甲烷 为溶剂， 反应 0.5h， 以2.9 g的产率得到5-oxo-1-phenylhexyl 4-methylbenzoate
  参考文献：
  名称：

  Organic electrosynthesis using toluates as simple and versatile radical precursors

  摘要：

  甲酸酯类化合物的电解顺利地导致了烷基片段自由基的形成。这一特性已被用于开发一种新的电化学脱氧反应。

  DOI：

  10.1039/b813545b
• 作为产物：
  描述：

  溴苯 、 5-oxohexanal 生成 6-Hydroxy-6-phenylhexan-2-one
  参考文献：
  名称：

  Vaskan,R.N.; Kovalev,B.G., Journal of Organic Chemistry USSR (English Translation), 1973, vol. 9, # 3, p. 501 - 503

  摘要：

  DOI：

文献信息

• Alpha-substituted carboxylic acid derivatives
  申请人：SANKYO COMPANY, LIMITED

  公开号：US20030069294A1

  公开（公告）日：2003-04-10

  The &agr;-substituted carboxylic acid derivatives having the formula (I): 1 wherein R 1 is an alkyl group, etc., R 2 is a hydrogen atom, etc., R 3 is a hydrogen atom, etc., A is ═CH-group, etc., B is an oxygen atom, etc., W 1 is a C 1 -C 8 alkylene group, W 2 is a single bond or a C 1 -C 8 alkylene group, X is a hydrogen atom, etc., Y is an oxygen atom, etc., and Z 1 is an alkoxy group, etc., and pharmacologically acceptable salts, esters and amides thereof are useful for treatment and/or prevention of diabetes mellitus, impaired glucose tolerance, gestational diabetes mellitus, or the like. Some of the derivatives of the formula (I) are novel compounds.

  具有如下式(I)的α-取代羧酸衍生物，其中R1是烷基基团，R2是氢原子，R3是氢原子，A是═CH-基团，B是氧原子，W1是C1-C8烷基基团，W2是单键或C1-C8烷基基团，X是氢原子，Y是氧原子，Z1是烷氧基团，其药理学上可接受的盐、酯和酰胺对于治疗和/或预防糖尿病、糖耐量受损、妊娠期糖尿病等疾病是有用的。其中一些具有如上式(I)的衍生物是新化合物。
• Medicinal compositions containing diuretic and insulin resistance-improving agent
  申请人：Takaoka Masaya

  公开号：US20050288339A1

  公开（公告）日：2005-12-29

  The present invention relates to a pharmaceutical composition comprising an insulin sensitizer and a diuretic which can prevent or treat side effects such as edema, cardiac enlargement, body fluid retension or hydrothorax caused by administration of an insulin sensitizer.

  本发明涉及一种药物组合物，包括胰岛素增敏剂和利尿剂，可以预防或治疗由于胰岛素增敏剂的使用引起的水肿、心脏肥大、体液潴留或胸水等副作用。
• ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES
  申请人：Sankyo Company, Limited

  公开号：EP1167357A1

  公开（公告）日：2002-01-02

  The α-substituted carboxylic acid derivatives having the general formula (I): [wherein R1 is an alkyl group, etc., R2 is a hydrogen atom, etc., R3 is a hydrogen atom, etc., A is = CH-group, etc., B is an oxygen atom, etc., W1 is a C1-C8 alkylene group, W2 is a single bond or a C1-C8 alkylene group, X is a hydrogen atom, etc., Y is an oxygen atom, etc., and Z1 is an alkoxy group, etc.], or pharmacologically acceptable salts thereof, pharmacologically acceptable esters thereof or pharmacologically acceptable amides thereof are useful as therapeutic agents and/or preventive agents for diabetes mellitus, glucose tolerance insufficiency, gestational diabetes mellitus, or the like.

  具有通式(I)的α-取代羧酸衍生物： [其中 R1 是烷基等，R2 是氢原子等，R3 是氢原子等，A 是＝CH-基团等，B 是氧原子等，W1 是 C1-C8 亚烷基，W2 是单键或 C1-C8 亚烷基，X 是氢原子等，Y 是氧原子等、和 Z1 是烷氧基等]，或其药理学上可接受的盐、药理学上可接受的酯或药理学上可接受的酰胺可用作糖尿病、葡萄糖耐量不足、妊娠糖尿病或类似疾病的治疗剂和/或预防剂。
• Medicinal compositions containing diuretics and insulin sensitizers
  申请人：Sankyo Company, Limited

  公开号：EP1695716A2

  公开（公告）日：2006-08-30

  The present invention relates to a pharmaceutical composition comprising an insulin sensitizer and a diuretic which can prevent or treat side effects such as edema, cardiac enlargement, body fluid retension or hydrothorax caused by administration of an insulin sensitizer.

  本发明涉及一种由胰岛素增敏剂和利尿剂组成的药物组合物，可预防或治疗因服用胰岛素增敏剂而引起的水肿、心脏扩大、体液潴留或水肿等副作用。
• MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT
  申请人：Sankyo Company, Limited

  公开号：EP1354602B1

  公开（公告）日：2006-10-04